Two new NIH grants were recently awarded involving Milk Bioactives group at FFHI. The first is a $2.7M grant from the National Cancer Institute is led by Yu-Jui Yvonne Wan, a professor and vice chair for research in the Department of Pathology and Laboratory Medicine and also involves Dr. Mills and Dr. Carolyn Slupsky (FST). The second grant is for $4.2M from the National Center for Complementary and Alternative Medicine is led by Dr. Mills and the FFHI Milk Bioactives Group (Drs. Lebrilla, German, Barile, Raybould). Both grants examine the use of dairy-based glycans and bifidobacteria as a means to ameliorate and repair the gut dybiosis. Dr. Mills is working with Hilmar Cheese Company on both these projects.
These projects were recently profiled in: